Bristol Myers Squibb Cash Flow from Investing Activities 2010-2025 | BMY
Bristol Myers Squibb cash flow from investing activities for the twelve months ending March 31, 2025 was $-63.944B, a 173.25% increase year-over-year.
- Bristol Myers Squibb annual cash flow from investing activities for 2024 was $-21.352B, a 830.37% increase from 2023.
- Bristol Myers Squibb annual cash flow from investing activities for 2023 was $-2.295B, a 116.1% increase from 2022.
- Bristol Myers Squibb annual cash flow from investing activities for 2022 was $-1.062B, a 97.4% increase from 2021.